ArticleScientific reports2025
Association between liver fibrosis scores and cardiovascular disease in elderly based on NHANES 1999-2018.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The association between liver fibrosis markers and carotid atherosclerosis in non-alcoholic fatty liver disease is strongly influenced by age.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to assess the association between liver fibrosis scores (LFSs) and cardiovascular disease (CVD) in older adults, investigating the mediating effect of total bilirubin (TBil) between LFSs and CVD. Using data from the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2018, this cross-sectional study analyzed Americans aged 60 and older. Four LFSs (Forns Score, FIB-4, NAFLD fibrosis score, and BARD Score) were utilized. Weighted logistic regression and smoothed curve fitting explored the relationship between LFSs and CVD. Subgroup analysis assessed this relationship among different populations. Mediation effect analysis examined the role of TBil. This study included 18,902 subjects, with a mean age of 69.64 ± 7.00 years and CVD prevalence of 22.33%. The fully adjusted weighted logistic regression models showed that FS, NFS, FIB-4 and BARD Score were positively associated with CVD with ORs of 1.50 (95% CI:1.37-1.64), 1.50 (95% CI:1.30-1.73), 1.39 (95% CI:1.18-1.64), and 1.54 (95% CI:1.29-1.85). Smoothed curve fitting indicated a nonlinear correlation between LFSs and CVD. Subgroup analysis indicated that the positive associations between FS, NFS, FIB-4, and CVD were consistent with respect to hepatitis B surface antigen, and the positive correlation between FIB-4, BARD Score, and CVD was coherent for the prevalence of hypertension. Mediation analysis revealed TBil mediated 12.61% of the association between FIB-4 and CVD. There exists a positive association between LFSs and CVD in older adults, and TBil mediates the relationship between FIB-4, and CVD. LFSs may serve as a tool for identifying older adults at high risk for cardiovascular disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.